Upstream Processing

Jan 28, 2016
By BioPharm International Editors
Novasep is building a new synthesis laboratory and adding capacity for kilogram-scale batches of synthetic molecules that are needed for biological testing and preclinical trials, at its Pennsylvania, US facility.
Jan 01, 2016
BioPharm International
The authors conclude that miniature bioreactors can adequately predict the cell culture kinetics in scaled-up reactors using equal mixing times.
Jan 01, 2016
BioPharm International
Could perfusion microbioreactors bring more agility to biomanufacturing?
Dec 01, 2015
BioPharm International
Use of a subspace model is a viable method to characterize process space variables and optimize process performance.
Nov 30, 2015
A study backed by the Centre of Regenerative Medicine found that laminins are crucial cell components that could help aid the commercial production of stem cell therapies.
Nov 01, 2015
BioPharm International
The authors present a review of the techniques commonly used for glycosylation analysis.
Oct 29, 2015
By BioPharm International Editors
ProBioGen plans to develop and scale-up production of a biosimilar to the mAb cancer drug trastuzumab and will transfer the commercial manufacturing process to Indonesia’s government-owned Bio Farma.
Oct 23, 2015
By BioPharm International Editors
Biovest’s mAbVault provides supply-chain redundancy for antibodies that enables customers to lock in price-per-gram protein production.
Oct 01, 2015
BioPharm International
The author explores the basic rationale and requirements for standardized glycan analysis.
Oct 01, 2015
BioPharm International
Taking immediate steps to address misidentified and contaminated cultured cell lines will improve the reproducibility of preclinical research.
lorem ipsum